BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,688,000 | -24.0% | 1,690,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,221,000 | +69.0% | 1,690,000 | +36.3% | 0.00% | – |
| Q1 2020 | $1,314,000 | -9.8% | 1,240,000 | -7.5% | 0.00% | – |
| Q4 2019 | $1,456,000 | +5.5% | 1,340,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,380,000 | +8.0% | 1,340,000 | +17.5% | 0.00% | – |
| Q2 2019 | $1,278,000 | -1.4% | 1,140,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,296,000 | +17.7% | 1,140,000 | +15.2% | 0.00% | – |
| Q4 2018 | $1,101,000 | +43.4% | 990,000 | +54.7% | 0.00% | – |
| Q3 2018 | $768,000 | +20.0% | 640,000 | +18.5% | 0.00% | – |
| Q2 2018 | $640,000 | -18.7% | 540,000 | -24.5% | 0.00% | – |
| Q1 2018 | $787,000 | -24.3% | 715,000 | -18.5% | 0.00% | – |
| Q4 2017 | $1,039,000 | -1.0% | 877,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,050,000 | +30.4% | 877,000 | +29.5% | 0.00% | – |
| Q2 2017 | $805,000 | +46.6% | 677,000 | +45.6% | 0.00% | – |
| Q1 2017 | $549,000 | +116.1% | 465,000 | +111.4% | 0.00% | – |
| Q2 2016 | $254,000 | -2.7% | 220,000 | 0.0% | 0.00% | – |
| Q1 2016 | $261,000 | -11.2% | 220,000 | 0.0% | 0.00% | – |
| Q4 2015 | $294,000 | -0.7% | 220,000 | 0.0% | 0.00% | – |
| Q3 2015 | $296,000 | -15.4% | 220,000 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $350,000 | +5.1% | 220,000 | 0.0% | 0.00% | – |
| Q1 2015 | $333,000 | +46.7% | 220,000 | +18.9% | 0.00% | – |
| Q4 2014 | $227,000 | +11.8% | 185,000 | 0.0% | 0.00% | – |
| Q3 2014 | $203,000 | +4.1% | 185,000 | 0.0% | 0.00% | – |
| Q2 2014 | $195,000 | -4.9% | 185,000 | 0.0% | 0.00% | – |
| Q1 2014 | $205,000 | +3.5% | 185,000 | 0.0% | 0.00% | – |
| Q4 2013 | $198,000 | – | 185,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |